Skip to main content
Veterinary Medicines

PM-Vac - inaktywowany paramyksowirus PMV-1 (szczep La Sota) > 1 j. ELISA;1 j. ELISA- ilość antygenu wystarczająca do uzyskania serokonwersji równej lub wyższej 1,8 u szczepionego gołębia Emulsja do wstrzykiwań

Authorised
  • Newcastle disease virus, strain La Sota, Inactivated

Product identification

Medicine name:
PM-Vac - inaktywowany paramyksowirus PMV-1 (szczep La Sota) > 1 j. ELISA;1 j. ELISA- ilość antygenu wystarczająca do uzyskania serokonwersji równej lub wyższej 1,8 u szczepionego gołębia Emulsja do wstrzykiwań
Active substance:
  • Newcastle disease virus, strain La Sota, Inactivated
Target species:
  • Pigeon
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, strain La Sota, Inactivated
    1.00
    unknown
    /
    0.20
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection/infusion
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pigeon
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01EA
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Biowet Pulawy Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biowet Pulawy Ltd.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0743
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."